ConductScience.org, home

Trial · NCT06315699

Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome

NCT06315699, Phase 2, Completed, Qilu Hospital of Shandong University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome. Trials, record NCT06315699. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06315699

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome
NCT number
NCT06315699
Status
Completed
Phases
Phase 2
Enrollment
28 participants, actual
Lead sponsor
Qilu Hospital of Shandong University
Conditions
Williams Syndrome, Child, Neurodevelopmental Delay
Interventions
Clemastine Fumarate Tablets, corn starch tablets
First posted
2024-03-18
Last updated
2026-03-19

Source ClinicalTrials.gov

Registered outcomes14

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAnisotropy Score (FA)baseline follow-up;D90; D194Measuring by Magnetic resonance diffusion tensor imaging (DTI)
PrimaryRadial diffusion rate (RD)baseline follow-up;second month;fourth monthMeasuring by Magnetic resonance diffusion tensor imaging (DTI)
Primaryaxial diffusivity (AD)baseline follow-up;D90;D194Measuring by Magnetic resonance diffusion tensor imaging (DTI)
Primarymean diffusivity (MD)baseline follow-up;D90; D194Measuring by Magnetic resonance diffusion tensor imaging (DTI)
PrimaryPeabody(Motion Estimation Timewarp)scorebaseline follow-up;second month;fourth monthAssessing motion skills
PrimaryGesell Development Scalebaseline follow-up;second month;fourth monthAssessing neurodevelopment
Primaryquotients (IQs) of the WISC-IVbaseline; D90 ; D194quantify intelligence quotients (IQs)
SecondaryDifferential pressure across valvesbaseline follow-up;second month;fourth monthMeasuring by Cardiac color ultrasound
SecondaryThyroid hormone valuebaseline follow-up;second month;fourth month
SecondaryConners Parent Symptoms Questionnaire Scorebaseline follow-up;second month;fourth monthAssessing adaptability

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06315699

GET https://conductscience.org/api/trials/v1/NCT06315699/registered